-
1
-
-
43749088730
-
Wound repair and regeneration
-
Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound repair and regeneration. Nature 2008á453(7193):314-21
-
(2008)
Nature
, vol.453
, Issue.7193
, pp. 314-321
-
-
Gurtner, G.C.1
Werner, S.2
Barrandon, Y.3
Longaker, M.T.4
-
2
-
-
70350680485
-
Human skin wounds: A major and snowballing threat to public health and the economy
-
Sen CK, Gordillo GM, Roy S, et al. Human skin wounds: A major and snowballing threat to public health and the economy. Wound Repair Regen 2009á17(6):763-71
-
(2009)
Wound Repair Regen
, vol.17
, Issue.6
, pp. 763-771
-
-
Sen, C.K.1
Gordillo, G.M.2
Roy, S.3
-
3
-
-
70349221407
-
Extracellular matrix biomaterials for soft tissue repair
-
Cornwell KG, Landsman A, James KS. Extracellular matrix biomaterials for soft tissue repair. Clin Podiatr Med Surg 2009á26(4):507-23
-
(2009)
Clin Podiatr Med Surg
, vol.26
, Issue.4
, pp. 507-523
-
-
Cornwell, K.G.1
Landsman, A.2
James, K.S.3
-
4
-
-
80051540487
-
A comparative, long-term assessment of four soft tissue substitutes
-
Cole PD, Stal D, Sharabi SE, et al. A comparative, long-term assessment of four soft tissue substitutes. Aesthet Surg J 2011á31(6):674-81
-
(2011)
Aesthet Surg J
, vol.31
, Issue.6
, pp. 674-681
-
-
Cole, P.D.1
Stal, D.2
Sharabi, S.E.3
-
5
-
-
33845408050
-
Extracellular matrix bioscaffolds for orthopaedic applications. A comparative histologic study
-
Valentin JE, Badylak JS, McCabe GP, Badylak SF. Extracellular matrix bioscaffolds for orthopaedic applications. A comparative histologic study. J Bone Joint Surg Am 2006á88(12):2673-86
-
(2006)
J Bone Joint Surg Am
, vol.88
, Issue.12
, pp. 2673-2686
-
-
Valentin, J.E.1
Badylak, J.S.2
McCabe, G.P.3
Badylak, S.F.4
-
6
-
-
84858128682
-
Histologic proof that acellular dermal matrices (adm)-enduragen, dermamatrix, and duramatrix-are not repopulated or nonviable and that alloderm may be repopulated but degraded synchronously
-
Wise DM. Histologic proof that acellular dermal matrices (ADM)-Enduragen, DermaMatrix, and DuraMatrix-are not repopulated or nonviable and that AlloDerm may be repopulated but degraded synchronously. Aesthet Surg J 2012á32(3):355-8
-
(2012)
Aesthet Surg J
, vol.32
, Issue.3
, pp. 355-358
-
-
Wise, D.M.1
-
7
-
-
79955624351
-
Histologic and biomechanical evaluation of crosslinked and non-crosslinked biologic meshes in a porcine model of ventral incisional hernia repair
-
Deeken CR, Melman L, Jenkins ED, et al. Histologic and biomechanical evaluation of crosslinked and non-crosslinked biologic meshes in a porcine model of ventral incisional hernia repair. J Am Coll Surg 2011á212(5):880-8
-
(2011)
J Am Coll Surg
, vol.212
, Issue.5
, pp. 880-888
-
-
Deeken, C.R.1
Melman, L.2
Jenkins, E.D.3
-
8
-
-
0029873786
-
Clinical evaluation of an acellular allograft dermal matrix in full-thickness burns
-
Wainwright D, Madden M, Luterman A, et al. Clinical evaluation of an acellular allograft dermal matrix in full-thickness burns. J Burn Care Rehabil 1996á17(2):124-36
-
(1996)
J Burn Care Rehabil
, vol.17
, Issue.2
, pp. 124-136
-
-
Wainwright, D.1
Madden, M.2
Luterman, A.3
-
9
-
-
0036165109
-
Use of alloderm for coverage of radial forearm free flap donor site
-
Sinha UK, Shih C, Chang K, Rice DH. Use of AlloDerm for coverage of radial forearm free flap donor site. Laryngoscope 2002á112(2):230-4
-
(2002)
Laryngoscope
, vol.112
, Issue.2
, pp. 230-234
-
-
Sinha, U.K.1
Shih, C.2
Chang, K.3
Rice, D.H.4
-
10
-
-
64349121738
-
Alloderm grafting for large wounds after mohs micrographic surgery
-
Kontos AP, Qian Z, Urato NS, et al. AlloDerm grafting for large wounds after Mohs micrographic surgery. Dermatol Surg 2009á35(4):692-8
-
(2009)
Dermatol Surg
, vol.35
, Issue.4
, pp. 692-698
-
-
Kontos, A.P.1
Qian, Z.2
Urato, N.S.3
-
11
-
-
77952791160
-
Scalp reconstruction: Regeneration with acellular dermal matrix
-
Kinsella CR Jr, Grunwaldt LJ, Cooper GM, et al. Scalp reconstruction: Regeneration with acellular dermal matrix. J Craniofac Surg 2010 21(2):605-7
-
(2010)
J Craniofac Surg
, vol.21
, Issue.2
, pp. 605-607
-
-
Kinsella Jr., C.R.1
Grunwaldt, L.J.2
Cooper, G.M.3
-
12
-
-
67649211100
-
Long-term outcome of acellular dermal matrix when used for large traumatic open abdomen
-
de Moya MA, Dunham M, Inaba K, et al. Long-term outcome of acellular dermal matrix when used for large traumatic open abdomen. J Traum 2008á65(2):349-53
-
(2008)
J Traum
, vol.65
, Issue.2
, pp. 349-353
-
-
De Moya, M.A.1
Dunham, M.2
Inaba, K.3
-
13
-
-
67650745184
-
Clinical effectiveness of an acellular dermal regenerative tissue matrix compared to standard wound management in healing diabetic foot ulcers: A prospective, randomised, multicentre study
-
Reyzelman A, Crews RT, Moore JC, et al. Clinical effectiveness of an acellular dermal regenerative tissue matrix compared to standard wound management in healing diabetic foot ulcers: A prospective, randomised, multicentre study. Int Wound J 2009á6(3):196-208
-
(2009)
Int Wound J
, vol.6
, Issue.3
, pp. 196-208
-
-
Reyzelman, A.1
Crews, R.T.2
Moore, J.C.3
-
14
-
-
33748906996
-
The use of an acellular dermal regenerative tissue matrix in the treatment of lower extremity wounds: A prospective 16-week pilot study
-
Brigido SA. The use of an acellular dermal regenerative tissue matrix in the treatment of lower extremity wounds: A prospective 16-week pilot study. Int Wound J 2006á3(3):181-7
-
(2006)
Int Wound J
, vol.3
, Issue.3
, pp. 181-187
-
-
Brigido, S.A.1
-
15
-
-
55949116467
-
A multicenter study involving the use of a human acellular dermal regenerative tissue matrix for the treatment of diabetic lower extremity wounds
-
Winters CL, Brigido SA, Liden BA, et al. A multicenter study involving the use of a human acellular dermal regenerative tissue matrix for the treatment of diabetic lower extremity wounds. Adv Skin Wound Care 2008á21(8):375- 81
-
(2008)
Adv Skin Wound Care
, vol.21
, Issue.8
, pp. 375-381
-
-
Winters, C.L.1
Brigido, S.A.2
Liden, B.A.3
-
16
-
-
28244478584
-
Outcomes of allogenic acellular matrix therapy in treatment of diabetic foot wounds: An initial experience
-
Martin BR, Sangalang M, Wu S, Armstrong DG. Outcomes of allogenic acellular matrix therapy in treatment of diabetic foot wounds: An initial experience. Int Wound J 2005á2(2):161-5
-
(2005)
Int Wound J
, vol.2
, Issue.2
, pp. 161-165
-
-
Martin, B.R.1
Sangalang, M.2
Wu, S.3
Armstrong, D.G.4
-
17
-
-
18844443478
-
Effectiveness of an extracellular matrix graft (oasis wound matrix) in the treatment of chronic leg ulcers: A randomized clinical trial
-
Mostow EN, Haraway GD, Dalsing M, et al. Effectiveness of an extracellular matrix graft (OASIS Wound Matrix) in the treatment of chronic leg ulcers: A randomized clinical trial. J Vascr Surg 2005á41(5):837-43
-
(2005)
J Vascr Surg
, vol.41
, Issue.5
, pp. 837-843
-
-
Mostow, E.N.1
Haraway, G.D.2
Dalsing, M.3
-
18
-
-
78651333929
-
Randomized comparison of oasis wound matrix versus moist wound dressing in the treatment of difficult-to-heal wounds of mixed arterialvenous etiology
-
Romanelli M, Dini V, Bertone MS. Randomized comparison of OASIS wound matrix versus moist wound dressing in the treatment of difficult-to-heal wounds of mixed arterial/venous etiology. Adv Skin Wound Care 2010 23(1):34-8
-
(2010)
Adv Skin Wound Care
, vol.23
, Issue.1
, pp. 34-38
-
-
Romanelli, M.1
Dini, V.2
Bertone, M.S.3
-
19
-
-
34147130727
-
Oasis wound matrix versus hyaloskin in the treatment of difficult-to-heal wounds of mixed arterial/venous aetiology
-
Romanelli M, Dini V, Bertone M, et al. OASIS wound matrix versus Hyaloskin in the treatment of difficult-to-heal wounds of mixed arterial/venous aetiology. Int Wound J 2007á4(1):3-7
-
(2007)
Int Wound J
, vol.4
, Issue.1
, pp. 3-7
-
-
Romanelli, M.1
Dini, V.2
Bertone, M.3
-
20
-
-
26944443743
-
Randomized clinical trial comparing oasis wound matrix to regranex gel for diabetic ulcers
-
Niezgoda JA, Van Gils CC, Frykberg RG, Hodde JP. Randomized clinical trial comparing OASIS Wound Matrix to Regranex Gel for diabetic ulcers. Adv Skin Wound Care 2005á18(5 Pt 1):258-66
-
(2005)
Adv Skin Wound Care
, vol.18
, Issue.5 PART 1
, pp. 258-266
-
-
Niezgoda, J.A.1
Van Gils, C.C.2
Frykberg, R.G.3
Hodde, J.P.4
-
21
-
-
14144249521
-
An investigation of the long-term bioactivity of endogenous growth factor in oasis wound matrix
-
Hodde JP, Ernst DM, Hiles MC. An investigation of the long-term bioactivity of endogenous growth factor in OASIS Wound Matrix. J Wound Care 2005á14(1):23-5
-
(2005)
J Wound Care
, vol.14
, Issue.1
, pp. 23-25
-
-
Hodde, J.P.1
Ernst, D.M.2
Hiles, M.C.3
-
22
-
-
0347384105
-
Transforming growth factor-beta1 in a sterilized tissue derived from the pig small intestine submucosa
-
McDevitt CA, Wildey GM, Cutrone RM. Transforming growth factor-beta1 in a sterilized tissue derived from the pig small intestine submucosa. J Biomed Mater Res A 2003á67(2):637-40
-
(2003)
J Biomed Mater Res A
, vol.67
, Issue.2
, pp. 637-640
-
-
McDevitt, C.A.1
Wildey, G.M.2
Cutrone, R.M.3
-
23
-
-
84864485227
-
Acellular fetal bovine dermal matrix for treatment of chronic ulcerations of the midfoot associated with charcot neuroarthropathy
-
Kavros SJ. Acellular fetal bovine dermal matrix for treatment of chronic ulcerations of the midfoot associated with Charcot neuroarthropathy. Foot Ankle Spec 2012á5(4):230-4
-
(2012)
Foot Ankle Spec
, vol.5
, Issue.4
, pp. 230-234
-
-
Kavros, S.J.1
-
24
-
-
84911808509
-
Successful treatment of complex traumatic and surgical wounds with a foetal bovine dermal matrix
-
March Epub ahead of print
-
Hayn E. Successful treatment of complex traumatic and surgical wounds with a foetal bovine dermal matrix. Int Wound J 2013 March. [Epub ahead of print]
-
(2013)
Int Wound J
-
-
Hayn, E.1
-
25
-
-
84861871106
-
Acellular fetal bovine dermal matrix in the treatment of nonhealing wounds in patients with complex comorbidities
-
Lullove E. Acellular fetal bovine dermal matrix in the treatment of nonhealing wounds in patients with complex comorbidities. J Am Podiat Med Assn 2012á102(3):233-9
-
(2012)
J Am Podiat Med Assn
, vol.102
, Issue.3
, pp. 233-239
-
-
Lullove, E.1
-
26
-
-
79957844291
-
Retrospective comparison of diabetic foot ulcer and venous stasis ulcer healing outcome between a dermal repair scaffold (PriMatrix) and a bilayered living cell therapy (Apligraf
-
Karr JC. Retrospective comparison of diabetic foot ulcer and venous stasis ulcer healing outcome between a dermal repair scaffold (PriMatrix) and a bilayered living cell therapy (Apligraf). Adv Skin Wound Care 2011á24(3):119-25
-
(2011)
Adv Skin Wound Care
, vol.24
, Issue.3
, pp. 119-125
-
-
Karr, J.C.1
-
27
-
-
84867756138
-
Porcine urinary bladder matrix: A retrospective study and establishment of protocol
-
478 480 482
-
Lecheminant J, Field C. Porcine urinary bladder matrix: A retrospective study and establishment of protocol. J Wound Care 2012á21(10):476á 478-480, 482
-
(2012)
J Wound Care
, vol.21
, Issue.10
, pp. 476
-
-
Lecheminant, J.1
Field, C.2
-
28
-
-
79960211429
-
The use of matriderm(r) and skin grafting in post-traumatic wounds
-
Cervelli V, Brinci L, Spallone D, et al. The use of MatriDerm(R) and skin grafting in post-traumatic wounds. Int Wound J 2011á8(4):400-5
-
(2011)
Int Wound J
, vol.8
, Issue.4
, pp. 400-405
-
-
Cervelli, V.1
Brinci, L.2
Spallone, D.3
-
29
-
-
77954700411
-
The use of matriderm and autologous skin grafting in the treatment of diabetic ulcers: A case report
-
Cervelli V, Lucarini L, Cerretani C, et al. The use of Matriderm and autologous skin grafting in the treatment of diabetic ulcers: A case report. Int Wound J 2010 7(4):291-6
-
(2010)
Int Wound J
, vol.7
, Issue.4
, pp. 291-296
-
-
Cervelli, V.1
Lucarini, L.2
Cerretani, C.3
-
30
-
-
0037254833
-
Multicenter postapproval clinical trial of integra dermal regeneration template for burn treatment
-
Heimbach DM, Warden GD, Luterman A, et al. Multicenter postapproval clinical trial of Integra dermal regeneration template for burn treatment. J Burn Care Rehabil 2003á24(1):42-8
-
(2003)
J Burn Care Rehabil
, vol.24
, Issue.1
, pp. 42-48
-
-
Heimbach, D.M.1
Warden, G.D.2
Luterman, A.3
-
31
-
-
84870212591
-
The treatment of bone exposure in burns by using artificial dermis
-
Yeong EK, Chen SH, Tang YB. The treatment of bone exposure in burns by using artificial dermis. Ann Plas Surg 2012á69(6):607-10
-
(2012)
Ann Plas Surg
, vol.69
, Issue.6
, pp. 607-610
-
-
Yeong, E.K.1
Chen, S.H.2
Tang, Y.B.3
-
32
-
-
39049166125
-
Longitudinal assessment of integra in primary burn management: A randomized pediatric clinical trial
-
Branski LK, Herndon DN, Pereira C, et al. Longitudinal assessment of Integra in primary burn management: A randomized pediatric clinical trial. Crit Care Med 2007á35(11):2615-23
-
(2007)
Crit Care Med
, vol.35
, Issue.11
, pp. 2615-2623
-
-
Branski, L.K.1
Herndon, D.N.2
Pereira, C.3
-
33
-
-
79151483480
-
Use of acellular dermal replacement in reconstruction of nonhealing lower extremity wounds
-
Kahn SA, Beers RJ, Lentz CW. Use of acellular dermal replacement in reconstruction of nonhealing lower extremity wounds. J Burn Care Res 2011á32(1):124-8
-
(2011)
J Burn Care Res
, vol.32
, Issue.1
, pp. 124-128
-
-
Kahn, S.A.1
Beers, R.J.2
Lentz, C.W.3
-
34
-
-
78650419018
-
Experience of integra((r)) in cancer reconstructive surgery
-
Chalmers RL, Smock E, Geh JL. Experience of Integra((R)) in cancer reconstructive surgery. J Plast Reconstr Aesthet Surg 2010 63(12):2081-90
-
(2010)
J Plast Reconstr Aesthet Surg
, vol.63
, Issue.12
, pp. 2081-2090
-
-
Chalmers, R.L.1
Smock, E.2
Geh, J.L.3
-
35
-
-
75449101032
-
One-stage integra reconstruction in head and neck defects
-
Burd A, Wong PS. One-stage integra reconstruction in head and neck defects. J Plast Reconstr Aesthet Surg 2010 63(3):404-9
-
(2010)
J Plast Reconstr Aesthet Surg
, vol.63
, Issue.3
, pp. 404-409
-
-
Burd, A.1
Wong, P.S.2
-
36
-
-
84867580483
-
Tendon coverage using an artificial skin substitute
-
Shores JT, Hiersche M, Gabriel A, Gupta S. Tendon coverage using an artificial skin substitute. J Plast Reconstr Aesthet Surg 2012á65(11): 1544-50
-
(2012)
J Plast Reconstr Aesthet Surg
, vol.65
, Issue.11
, pp. 1544-1550
-
-
Shores, J.T.1
Hiersche, M.2
Gabriel, A.3
Gupta, S.4
-
37
-
-
79952849213
-
Management of severe hand wounds with integra(r) dermal regeneration template
-
Weigert R, Choughri H, Casoli V. Management of severe hand wounds with Integra(R) dermal regeneration template. J Hand Surg Eur Vol 2011á36(3):185-93
-
(2011)
J Hand Surg Eur Vol
, vol.36
, Issue.3
, pp. 185-193
-
-
Weigert, R.1
Choughri, H.2
Casoli, V.3
-
38
-
-
0025229005
-
Histologic study of artificial skin used in the treatment of full-thickness thermal injury
-
Stern R, McPherson M, Longaker MT. Histologic study of artificial skin used in the treatment of full-thickness thermal injury. J Burn Care Rehabil 1990á11(1):7-13
-
(1990)
J Burn Care Rehabil
, vol.11
, Issue.1
, pp. 7-13
-
-
Stern, R.1
McPherson, M.2
Longaker, M.T.3
-
39
-
-
33745498124
-
Reconstructive surgery with Integra dermal regeneration template: Histologic study, clinical evaluation, and current practice
-
Moiemen NS, Vlachou E, Staiano JJ, et al. Reconstructive surgery with Integra dermal regeneration template: Histologic study, clinical evaluation, and current practice. Plast Reconstr Surg 2006á117(7 Suppl):160S-74S
-
(2006)
Plast Reconstr Surg
, vol.117
, Issue.7 SUPPL.
-
-
Moiemen, N.S.1
Vlachou, E.2
Staiano, J.J.3
-
40
-
-
79952760467
-
Long-term clinical and histological analysis of Integra dermal regeneration template
-
Moiemen N, Yarrow J, Hodgson E, et al. Long-term clinical and histological analysis of Integra dermal regeneration template. Plast Reconstr Surg 2011á127(3):1149-54
-
(2011)
Plast Reconstr Surg
, vol.127
, Issue.3
, pp. 1149-1154
-
-
Moiemen, N.1
Yarrow, J.2
Hodgson, E.3
-
41
-
-
33846243277
-
Seven years' experience with integra as a reconstructive tool
-
Jeng JC, Fidler PE, Sokolich JC, et al. Seven years' experience with Integra as a reconstructive tool. J Burn Care Res 2007á28(1):120-6
-
(2007)
J Burn Care Res
, vol.28
, Issue.1
, pp. 120-126
-
-
Jeng, J.C.1
Fidler, P.E.2
Sokolich, J.C.3
-
42
-
-
84885660899
-
Comparision of clinical and histopathological results of hyalomatrix usage in adult patients
-
Erbatur S, Coban YK, Aydin EN. Comparision of clinical and histopathological results of hyalomatrix usage in adult patients. Int J Burns Trauma 2012á2(2):118-25
-
(2012)
Int J Burns Trauma
, vol.2
, Issue.2
, pp. 118-125
-
-
Erbatur, S.1
Coban, Y.K.2
Aydin, E.N.3
-
43
-
-
76149105489
-
Hyalomatrix pa in burn care practice: Results from a national retrospective survey 2005 to 2006
-
Gravante G, Sorge R, Merone A, et al. Hyalomatrix PA in burn care practice: Results from a national retrospective survey, 2005 to 2006. Ann Plas Surg 2010 64(1):69-79
-
(2010)
Ann Plas Surg
, vol.64
, Issue.1
, pp. 69-79
-
-
Gravante, G.1
Sorge, R.2
Merone, A.3
-
44
-
-
33947177992
-
The use of hyalomatrix pa in the treatment of deep partial-thickness burns
-
Gravante G, Delogu D, Giordan N, et al. The use of Hyalomatrix PA in the treatment of deep partial-thickness burns. J Burn Care Res 2007á28(2): 269-74
-
(2007)
J Burn Care Res
, vol.28
, Issue.2
, pp. 269-274
-
-
Gravante, G.1
Delogu, D.2
Giordan, N.3
-
45
-
-
0027301753
-
Evaporative water losses through a temporary wound dressing under simulated wound conditions
-
Gwosdow AR, Cunningham JJ, Lydon M, et al. Evaporative water losses through a temporary wound dressing under simulated wound conditions. J Burn Care Rehabil 1993á14(4):450-4
-
(1993)
J Burn Care Rehabil
, vol.14
, Issue.4
, pp. 450-454
-
-
Gwosdow, A.R.1
Cunningham, J.J.2
Lydon, M.3
-
46
-
-
27644484481
-
Biobrane in the treatment of burn and scald injuries in children
-
Lang EM, Eiberg CA, Brandis M, Stark GB. Biobrane in the treatment of burn and scald injuries in children. Ann Plas Surg 2005á55(5):485-9
-
(2005)
Ann Plas Surg
, vol.55
, Issue.5
, pp. 485-489
-
-
Lang, E.M.1
Eiberg, C.A.2
Brandis, M.3
Stark, G.B.4
-
47
-
-
0032007719
-
Use of biobrane in pediatric scald burns-experience in 106 children
-
Ou LF, Lee SY, Chen YC, et al. Use of Biobrane in pediatric scald burns-experience in 106 children. Burns 1998á24(1):49-53
-
(1998)
Burns
, vol.24
, Issue.1
, pp. 49-53
-
-
Ou, L.F.1
Lee, S.Y.2
Chen, Y.C.3
-
48
-
-
79955072213
-
Biobrane: A retrospective analysis of outcomes at a specialist adult burns centre
-
Hubik DJ, Wasiak J, Paul E, Cleland H. Biobrane: A retrospective analysis of outcomes at a specialist adult burns centre. Burns 2011á37(4):594-600
-
(2011)
Burns
, vol.37
, Issue.4
, pp. 594-600
-
-
Hubik, D.J.1
Wasiak, J.2
Paul, E.3
Cleland, H.4
-
49
-
-
4444325751
-
Treatment of partial-thickness burns: A prospective, randomized trial using transcyte
-
Kumar RJ, Kimble RM, Boots R, Pegg SP. Treatment of partial-thickness burns: A prospective, randomized trial using Transcyte. ANZ J Surg 2004á74(8):622-6
-
(2004)
ANZ J Surg
, vol.74
, Issue.8
, pp. 622-626
-
-
Kumar, R.J.1
Kimble, R.M.2
Boots, R.3
Pegg, S.P.4
-
50
-
-
0033982138
-
Biobrane versus 1% silver sulfadiazine in second-degree pediatric burns
-
Barret JP, Dziewulski P, Ramzy PI, et al. Biobrane versus 1% silver sulfadiazine in second-degree pediatric burns. Plast Reconstr Surg 2000á105(1):62-5
-
(2000)
Plast Reconstr Surg
, vol.105
, Issue.1
, pp. 62-65
-
-
Barret, J.P.1
Dziewulski, P.2
Ramzy, P.I.3
-
51
-
-
80052973417
-
Effectiveness of biobrane for treatment of partial-thickness burns in children
-
Lesher AP, Curry RH, Evans J, et al. Effectiveness of Biobrane for treatment of partial-thickness burns in children. J Pediatr Surg 2011á46(9):1759-63
-
(2011)
J Pediatr Surg
, vol.46
, Issue.9
, pp. 1759-1763
-
-
Lesher, A.P.1
Curry, R.H.2
Evans, J.3
-
52
-
-
80855130823
-
A clinical evaluation of biobrane((r)) and suprathel((r)) in acute burns and reconstructive surgery
-
Rahmanian-Schwarz A, Beiderwieden A, Willkomm LM, et al. A clinical evaluation of Biobrane((R)) and Suprathel((R)) in acute burns and reconstructive surgery. Burns 2011á37(8):1343-8
-
(2011)
Burns
, vol.37
, Issue.8
, pp. 1343-1348
-
-
Rahmanian-Schwarz, A.1
Beiderwieden, A.2
Willkomm, L.M.3
-
53
-
-
25844454524
-
Biobrane versus duoderm for the treatment of intermediate thickness burns in children: A prospective randomized trial
-
Cassidy C, St Peter SD, Lacey S, et al. Biobrane versus duoderm for the treatment of intermediate thickness burns in children: A prospective, randomized trial. Burns 2005á31(7):890-3
-
(2005)
Burns
, vol.31
, Issue.7
, pp. 890-893
-
-
Cassidy, C.1
St Peter, S.D.2
Lacey, S.3
-
54
-
-
84872021953
-
Use of suprathel(r) for partial thickness burns in children
-
Highton L, Wallace C, Shah M. Use of Suprathel(R) for partial thickness burns in children. Burns 2013á39(1):136-41
-
(2013)
Burns
, vol.39
, Issue.1
, pp. 136-141
-
-
Highton, L.1
Wallace, C.2
Shah, M.3
-
55
-
-
84858074519
-
The use of suprathel((r)) in deep dermal burns: First results of a prospective study
-
Keck M, Selig HF, Lumenta DB, et al. The use of Suprathel((R)) in deep dermal burns: First results of a prospective study. Burns 2012á38(3):388- 95
-
(2012)
Burns
, vol.38
, Issue.3
, pp. 388-395
-
-
Keck, M.1
Selig, H.F.2
Lumenta, D.B.3
-
56
-
-
38749086533
-
Suprathel a new skin substitute in the management of partial-thickness burn wounds: Results of a clinical study
-
Schwarze H, Kuntscher M, Uhlig C, et al. Suprathel, a new skin substitute, in the management of partial-thickness burn wounds: Results of a clinical study. Ann Plas Surg 2008á60(2):181-5
-
(2008)
Ann Plas Surg
, vol.60
, Issue.2
, pp. 181-185
-
-
Schwarze, H.1
Kuntscher, M.2
Uhlig, C.3
-
57
-
-
0035140758
-
Graftskin a human skin equivalent is effective in the management of noninfected neuropathic diabetic foot ulcers: A prospective randomized multicenter clinical trial
-
Veves A, Falanga V, Armstrong DG, Sabolinski ML. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: A prospective randomized multicenter clinical trial. Diabetes Care 2001á24(2):290-5
-
(2001)
Diabetes Care
, vol.24
, Issue.2
, pp. 290-295
-
-
Veves, A.1
Falanga, V.2
Armstrong, D.G.3
Sabolinski, M.L.4
-
58
-
-
62149092828
-
Apligraf in the treatment of neuropathic diabetic foot ulcers
-
Edmonds M. Apligraf in the treatment of neuropathic diabetic foot ulcers. Int J Low Extrem Wounds 2009á8(1):11-18
-
(2009)
Int J Low Extrem Wounds
, vol.8
, Issue.1
, pp. 11-18
-
-
Edmonds, M.1
-
59
-
-
0032870326
-
A bilayered living skin construct (apligraf) accelerates complete closure of hard-to-heal venous ulcers
-
Falanga V, Sabolinski M. A bilayered living skin construct (APLIGRAF) accelerates complete closure of hard-to-heal venous ulcers. Wound Repair Regen 1999á7(4):201-7
-
(1999)
Wound Repair Regen
, vol.7
, Issue.4
, pp. 201-207
-
-
Falanga, V.1
Sabolinski, M.2
-
60
-
-
0034089949
-
Healing of diabetic foot ulcers and pressure ulcers with human skin equivalent: A new paradigm in wound healing
-
Brem H, Balledux J, Bloom T, et al. Healing of diabetic foot ulcers and pressure ulcers with human skin equivalent: A new paradigm in wound healing. Arch Surg 2000á135(6):627-34
-
(2000)
Arch Surg
, vol.135
, Issue.6
, pp. 627-634
-
-
Brem, H.1
Balledux, J.2
Bloom, T.3
-
61
-
-
0035661694
-
Treatment of refractory, atypical lower extremity ulcers with tissue-engineered skin (apligraf
-
Long RE, Falabella AF, Valencia I, et al. Treatment of refractory, atypical lower extremity ulcers with tissue-engineered skin (Apligraf). Arch Dermatol 2001á137(12):1660-1
-
(2001)
Arch Dermatol
, vol.137
, Issue.12
, pp. 1660-1661
-
-
Long, R.E.1
Falabella, A.F.2
Valencia, I.3
-
62
-
-
0035191587
-
Healing of venous ulcers of long duration with a bilayered living skin substitute: Results from a general surgery and dermatology department
-
Brem H, Balledux J, Sukkarieh T, et al. Healing of venous ulcers of long duration with a bilayered living skin substitute: Results from a general surgery and dermatology department. Dermatol Surg 2001á27(11):915-19
-
(2001)
Dermatol Surg
, vol.27
, Issue.11
, pp. 915-919
-
-
Brem, H.1
Balledux, J.2
Sukkarieh, T.3
-
63
-
-
77955883406
-
Advanced biological therapies for diabetic foot ulcers
-
Kirsner RS, Warriner R, Michela M, et al. Advanced biological therapies for diabetic foot ulcers. Arch Dermatol 2010 146(8):857-62
-
(2010)
Arch Dermatol
, vol.146
, Issue.8
, pp. 857-862
-
-
Kirsner, R.S.1
Warriner, R.2
Michela, M.3
-
64
-
-
33750125838
-
Experience with the use of apligraf to heal complicated surgical and nonsurgical wounds in a private practice setting
-
Shealy FG Jr, DeLoach ED. Experience with the use of apligraf to heal complicated surgical and nonsurgical wounds in a private practice setting. Adv Skin Wound Care 2006á19(6):310-22
-
(2006)
Adv Skin Wound Care
, vol.19
, Issue.6
, pp. 310-322
-
-
Shealy Jr., F.G.1
DeLoach, E.D.2
-
65
-
-
0034333782
-
The effect of a tissue engineered bilayered living skin analog, over meshed split-thickness autografts on the healing of excised burn wounds the apligraf burn study group
-
Waymack P, Duff RG, Sabolinski M. The effect of a tissue engineered bilayered living skin analog, over meshed split-thickness autografts on the healing of excised burn wounds. The Apligraf Burn Study Group. Burns 2000á26(7):609-19
-
(2000)
Burns
, vol.26
, Issue.7
, pp. 609-619
-
-
Waymack, P.1
Duff, R.G.2
Sabolinski, M.3
-
66
-
-
0036181530
-
Epidermal-dermal interactions regulate gelatinase activity in apligraf, a tissue-engineered human skin equivalent
-
Osborne CS, Schmid P. Epidermal-dermal interactions regulate gelatinase activity in Apligraf, a tissue-engineered human skin equivalent. Br J Dermatol 2002á146(1):26-31
-
(2002)
Br J Dermatol
, vol.146
, Issue.1
, pp. 26-31
-
-
Osborne, C.S.1
Schmid, P.2
-
67
-
-
33747619395
-
Evaluation of apligraf persistence and basement membrane restoration in donor site wounds: A pilot study
-
Hu S, Kirsner RS, Falanga V, et al. Evaluation of Apligraf persistence and basement membrane restoration in donor site wounds: A pilot study. Wound Repair Regen 2006á14(4):427-33
-
(2006)
Wound Repair Regen
, vol.14
, Issue.4
, pp. 427-433
-
-
Hu, S.1
Kirsner, R.S.2
Falanga, V.3
-
68
-
-
4544365910
-
Survival of apligraf in acute human wounds
-
Griffiths M, Ojeh N, Livingstone R, et al. Survival of Apligraf in acute human wounds. Tissue Eng 2004á10(7-8):1180-95
-
(2004)
Tissue Eng
, vol.10
, Issue.7-8
, pp. 1180-1195
-
-
Griffiths, M.1
Ojeh, N.2
Livingstone, R.3
-
69
-
-
38449120873
-
A review of a bi-layered living cell treatment (apligraf) in the treatment of venous leg ulcers and diabetic foot ulcers
-
Zaulyanov L, Kirsner RS. A review of a bi-layered living cell treatment (Apligraf) in the treatment of venous leg ulcers and diabetic foot ulcers. Clin Interv Aging 2007á2(1):93-8
-
(2007)
Clin Interv Aging
, vol.2
, Issue.1
, pp. 93-98
-
-
Zaulyanov, L.1
Kirsner, R.S.2
-
70
-
-
0043171152
-
The efficacy and safety of dermagraft in improving the healing of chronic diabetic foot ulcers: Results of a prospective randomized trial
-
Marston WA, Hanft J, Norwood P, Pollak R. The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: Results of a prospective randomized trial. Diabetes Care 2003á26(6):1701-5
-
(2003)
Diabetes Care
, vol.26
, Issue.6
, pp. 1701-1705
-
-
Marston, W.A.1
Hanft, J.2
Norwood, P.3
Pollak, R.4
-
71
-
-
0036749731
-
Healing of chronic foot ulcers in diabetic patients treated with a human fibroblast-derived dermis
-
Hanft JR, Surprenant MS. Healing of chronic foot ulcers in diabetic patients treated with a human fibroblast-derived dermis. J Foot Ankle Surg 2002á41(5):291-9
-
(2002)
J Foot Ankle Surg
, vol.41
, Issue.5
, pp. 291-299
-
-
Hanft, J.R.1
Surprenant, M.S.2
-
72
-
-
0029991342
-
Use of dermagraft a cultured human dermis to treat diabetic foot ulcers
-
Gentzkow GD, Iwasaki SD, Hershon KS, et al. Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care 1996á19(4): 350-4
-
(1996)
Diabetes Care
, vol.19
, Issue.4
, pp. 350-354
-
-
Gentzkow, G.D.1
Iwasaki, S.D.2
Hershon, K.S.3
-
73
-
-
2442492958
-
Treatment of venous leg ulcers with dermagraft
-
Omar AA, Mavor AI, Jones AM, Homer-Vanniasinkam S. Treatment of venous leg ulcers with Dermagraft. Eur J Vasc Endovas 2004á27(6):666-72
-
(2004)
Eur J Vasc Endovas
, vol.27
, Issue.6
, pp. 666-672
-
-
Omar, A.A.1
Mavor, A.I.2
Jones, A.M.3
Homer-Vanniasinkam, S.4
-
74
-
-
0026781128
-
Clinical trials of a living dermal tissue replacement placed beneath meshed, split-thickness skin grafts on excised burn wounds
-
Hansbrough JF, Dore C, Hansbrough WB. Clinical trials of a living dermal tissue replacement placed beneath meshed, split-thickness skin grafts on excised burn wounds. J Burn Care Rehabil 1992á13(5):519-29
-
(1992)
J Burn Care Rehabil
, vol.13
, Issue.5
, pp. 519-529
-
-
Hansbrough, J.F.1
Dore, C.2
Hansbrough, W.B.3
-
75
-
-
0031037448
-
A multicenter clinical trial of a biosynthetic skin replacement, dermagraft-tc, compared with cryopreserved human cadaver skin for temporary coverage of excised burn wounds
-
Purdue GF, Hunt JL, Still JM Jr, et al. A multicenter clinical trial of a biosynthetic skin replacement, Dermagraft-TC, compared with cryopreserved human cadaver skin for temporary coverage of excised burn wounds. J Burn Care Rehabil 1997á18(1 Pt 1):52-7
-
(1997)
J Burn Care Rehabil
, vol.18
, Issue.1 PART 1
, pp. 52-57
-
-
Purdue, G.F.1
Hunt, J.L.2
Still Jr., J.M.3
-
76
-
-
68149173150
-
Phase i/ii clinical evaluation of stratagraft: A consistent, pathogen-free human skin substitute
-
discussion 873-864
-
Schurr MJ, Foster KN, Centanni JM, et al. Phase I/II clinical evaluation of StrataGraft: A consistent, pathogen-free human skin substitute. J Trauma 2009á66(3):866-73á discussion 873-864
-
(2009)
J Trauma
, vol.66
, Issue.3
, pp. 866-873
-
-
Schurr, M.J.1
Foster, K.N.2
Centanni, J.M.3
-
77
-
-
0034126411
-
Cultured epithelial autografts in extensive burn coverage of severely traumatized patients: A five year single-center experience with 30 patients
-
Carsin H, Ainaud P, Le Bever H, et al. Cultured epithelial autografts in extensive burn coverage of severely traumatized patients: A five year single-center experience with 30 patients. Burns 2000á26(4):379-87
-
(2000)
Burns
, vol.26
, Issue.4
, pp. 379-387
-
-
Carsin, H.1
Ainaud, P.2
Le Bever, H.3
-
78
-
-
79959534252
-
Two-step autologous grafting using hyaff scaffolds in treating difficult diabetic foot ulcers: Results of a multicenter, randomized controlled clinical trial with long-term follow-up
-
Uccioli L, Giurato L, Ruotolo V, et al. Two-step autologous grafting using HYAFF scaffolds in treating difficult diabetic foot ulcers: Results of a multicenter, randomized controlled clinical trial with long-term follow-up. Int J Low Extrem Wounds 2011á10(2):80-5
-
(2011)
Int J Low Extrem Wounds
, vol.10
, Issue.2
, pp. 80-85
-
-
Uccioli, L.1
Giurato, L.2
Ruotolo, V.3
-
79
-
-
84864835746
-
Clinical and cost efficacy of advanced wound care matrices for venous ulcers
-
Hankin CS, Knispel J, Lopes M, et al. Clinical and cost efficacy of advanced wound care matrices for venous ulcers. J Manag Care Pharm 2012á18(5):375-84
-
(2012)
J Manag Care Pharm
, vol.18
, Issue.5
, pp. 375-384
-
-
Hankin, C.S.1
Knispel, J.2
Lopes, M.3
-
80
-
-
0034066856
-
Cost-effectiveness modeling of dermagraft for the treatment of diabetic foot ulcers in the french context
-
Allenet B, Paree F, Lebrun T, et al. Cost-effectiveness modeling of Dermagraft for the treatment of diabetic foot ulcers in the french context. Diabetes Metab 2000á26(2):125-32
-
(2000)
Diabetes Metab
, vol.26
, Issue.2
, pp. 125-132
-
-
Allenet, B.1
Paree, F.2
Lebrun, T.3
-
82
-
-
64849116779
-
The role of vascular endothelial growth factor in wound healing
-
Bao P, Kodra A, Tomic-Canic M, et al. The role of vascular endothelial growth factor in wound healing. J Surg Res 2009á153(2):347-58
-
(2009)
J Surg Res
, vol.153
, Issue.2
, pp. 347-358
-
-
Bao, P.1
Kodra, A.2
Tomic-Canic, M.3
-
83
-
-
0032875460
-
Mechanism of action and in vivo role of platelet-derived growth factor
-
Heldin CH, Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 1999á79(4):1283-316
-
(1999)
Physiol Rev
, vol.79
, Issue.4
, pp. 1283-1316
-
-
Heldin, C.H.1
Westermark, B.2
-
84
-
-
0025894052
-
Role of platelet-derived growth factor in wound healing
-
Pierce GF, Mustoe TA, Altrock BW, et al. Role of platelet-derived growth factor in wound healing. J Cell Biochem 1991á45(4):319-26
-
(1991)
J Cell Biochem
, vol.45
, Issue.4
, pp. 319-326
-
-
Pierce, G.F.1
Mustoe, T.A.2
Altrock, B.W.3
-
85
-
-
0347990559
-
Mechanism of human dermal fibroblast migration driven by type i collagen and platelet-derived growth factor-bb
-
Li W, Fan J, Chen M, et al. Mechanism of human dermal fibroblast migration driven by type I collagen and platelet-derived growth factor-BB. Mol Biol Cell 2004á15(1):294-309
-
(2004)
Mol Biol Cell
, vol.15
, Issue.1
, pp. 294-309
-
-
Li, W.1
Fan, J.2
Chen, M.3
-
86
-
-
0036318172
-
Topical platelet-derived growth factor enhances wound closure in the absence of wound contraction: An experimental and clinical study
-
discussion 66
-
Saba AA, Freedman BM, Gaffield JW, et al. Topical platelet-derived growth factor enhances wound closure in the absence of wound contraction: An experimental and clinical study. Ann Plas Surg 2002á49(1):62-6á discussion 66
-
(2002)
Ann Plas Surg
, vol.49
, Issue.1
, pp. 62-66
-
-
Saba, A.A.1
Freedman, B.M.2
Gaffield, J.W.3
-
87
-
-
0032720053
-
Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-bb) in patients with nonhealing lower extremity diabetic ulcers: A combined analysis of four randomized studies
-
Smiell JM, Wieman TJ, Steed DL, et al. Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: A combined analysis of four randomized studies. Wound Repair Regen 1999á7(5):335-46
-
(1999)
Wound Repair Regen
, vol.7
, Issue.5
, pp. 335-346
-
-
Smiell, J.M.1
Wieman, T.J.2
Steed, D.L.3
-
88
-
-
0032790021
-
Becaplermin gel in the treatment of pressure ulcers: A phase ii randomized double-blind placebo-controlled study
-
Rees RS, Robson MC, Smiell JM, Perry BH. Becaplermin gel in the treatment of pressure ulcers: A Phase II randomized, double-blind, placebo-controlled study. Wound Repair Regen 1999á7(3):141-7
-
(1999)
Wound Repair Regen
, vol.7
, Issue.3
, pp. 141-147
-
-
Rees, R.S.1
Robson, M.C.2
Smiell, J.M.3
Perry, B.H.4
-
89
-
-
77952793213
-
Analysis of patient cost for recombinant human platelet-derived growth factor therapy as the first-line treatment of the insured patient with a diabetic foot ulcer
-
Lantis JC II, Boone D, Gendics C, Todd G. Analysis of patient cost for recombinant human platelet-derived growth factor therapy as the first-line treatment of the insured patient with a diabetic foot ulcer. Adv Skin Wound Care 2009á22(4):167-71
-
(2009)
Adv Skin Wound Care
, vol.22
, Issue.4
, pp. 167-171
-
-
Lantis II, J.C.1
Boone, D.2
Gendics, C.3
Todd, G.4
-
90
-
-
80051685663
-
Topical treatment of hypertensive leg ulcers with platelet-derived growth factor- bb: A randomized controlled trial
-
Senet P, Vicaut E, Beneton N, et al. Topical treatment of hypertensive leg ulcers with platelet-derived growth factor- BB: A randomized controlled trial. Arch Dermatol 2011á147(8):926-30
-
(2011)
Arch Dermatol
, vol.147
, Issue.8
, pp. 926-930
-
-
Senet, P.1
Vicaut, E.2
Beneton, N.3
-
91
-
-
84885670033
-
-
Autologous Platelet Derived Growth Factor Available at Last accessed 16 June 2013]
-
Autologous Platelet Derived Growth Factor. Fallon Community Health Plan. 2009. Available at http://www.fchp.org/ ~/media/Files/ProviderPDFs/ MedicalPolicies/Autologous- PlateletDerivedProducts.ashx [Last accessed 16 June 2013]
-
(2009)
Fallon Community Health Plan
-
-
-
92
-
-
81155148171
-
Analysis of run-in and treatment data in a wound outcomes registry: Clinical impact of topical platelet-rich plasma gel on healing trajectory
-
Carter MJ, Fylling CP, Li WW, et al. Analysis of run-in and treatment data in a wound outcomes registry: Clinical impact of topical platelet-rich plasma gel on healing trajectory. Int Wound J 2011á8(6):638-50
-
(2011)
Int Wound J
, vol.8
, Issue.6
, pp. 638-650
-
-
Carter, M.J.1
Fylling, C.P.2
Li, W.W.3
-
93
-
-
33747621370
-
A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers
-
72 74 passim
-
Driver VR, Hanft J, Fylling CP, Beriou JM. A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers. Ostomy Wound Manage 2006á52(6):68-70á 72, 74 passim
-
(2006)
Ostomy Wound Manage
, vol.52
, Issue.6
, pp. 68-70
-
-
Driver, V.R.1
Hanft, J.2
Fylling, C.P.3
Beriou, J.M.4
-
94
-
-
33644632508
-
Catrix an easy-to-use collagen treatment for wound healing
-
King S. Catrix: An easy-to-use collagen treatment for wound healing. Br J Community Nurs 2005á10(9):S31-4
-
(2005)
Br J Community Nurs
, vol.10
, Issue.9
-
-
King, S.1
-
95
-
-
84866173711
-
Spray-applied cell therapy with human allogeneic fibroblasts and keratinocytes for the treatment of chronic venous leg ulcers: A phase ii multicentre double-blind randomised placebo-controlled trial
-
Kirsner RS, Marston WA, Snyder RJ, et al. Spray-applied cell therapy with human allogeneic fibroblasts and keratinocytes for the treatment of chronic venous leg ulcers: A phase II, multicentre, double-blind, randomised, placebo-controlled trial. Lancet 2012á380(9846):977-85
-
(2012)
Lancet
, vol.380
, Issue.9846
, pp. 977-985
-
-
Kirsner, R.S.1
Marston, W.A.2
Snyder, R.J.3
-
96
-
-
79959951133
-
The MSC: An injury drugstore
-
Caplan AI, Correa D. The MSC: An injury drugstore. Cell Stem Cell 2011á9(1):11-15
-
(2011)
Cell Stem Cell
, vol.9
, Issue.1
, pp. 11-15
-
-
Caplan, A.I.1
Correa, D.2
-
97
-
-
3543018487
-
Human embryonic stem cells possess immune-privileged properties
-
Li L, Baroja ML, Majumdar A, et al. Human embryonic stem cells possess immune-privileged properties. Stem Cells 2004á22(4):448-56
-
(2004)
Stem Cells
, vol.22
, Issue.4
, pp. 448-456
-
-
Li, L.1
Baroja, M.L.2
Majumdar, A.3
-
98
-
-
84866859990
-
Mesenchymal stromal cells: A key player in 'innate tolerance'?
-
Dazzi F, Lopes L, Weng L. Mesenchymal stromal cells: A key player in 'innate tolerance'? Immunology 2012á137(3):206-13
-
(2012)
Immunology
, vol.137
, Issue.3
, pp. 206-213
-
-
Dazzi, F.1
Lopes, L.2
Weng, L.3
-
99
-
-
84873422794
-
Human mesenchymal stem cell grafts enhance normal and impaired wound healing by recruiting existing endogenous tissue stemprogenitor cells
-
Shin L, Peterson DA. Human mesenchymal stem cell grafts enhance normal and impaired wound healing by recruiting existing endogenous tissue stem/progenitor cells. Stem Cells Transl Med 2013á2(1):33-42
-
(2013)
Stem Cells Transl Med
, vol.2
, Issue.1
, pp. 33-42
-
-
Shin, L.1
Peterson, D.A.2
-
100
-
-
82855161330
-
Enhancement of mesenchymal stem cell angiogenic capacity and stemness by a biomimetic hydrogel scaffold
-
Rustad KC, Wong VW, Sorkin M, et al. Enhancement of mesenchymal stem cell angiogenic capacity and stemness by a biomimetic hydrogel scaffold. Biomaterials 2012á33(1):80-90
-
(2012)
Biomaterials
, vol.33
, Issue.1
, pp. 80-90
-
-
Rustad, K.C.1
Wong, V.W.2
Sorkin, M.3
-
101
-
-
84872076821
-
The use of adipose tissue-derived stem cells within a dermal substitute improves skin regeneration by increasing neoangiogenesis and collagen synthesis
-
Chang P, Tao K. The use of adipose tissue-derived stem cells within a dermal substitute improves skin regeneration by increasing neoangiogenesis and collagen synthesis. Plast Reconstr Surg 2013á131(1):116e-7e
-
(2013)
Plast Reconstr Surg
, vol.131
, Issue.1
-
-
Chang, P.1
Tao, K.2
-
102
-
-
77954829915
-
Integration of blood outgrowth endothelial cells in dermal fibroblast sheets promotes full thickness wound healing
-
Hendrickx B, Verdonck K, Van Den Berge S, et al. Integration of blood outgrowth endothelial cells in dermal fibroblast sheets promotes full thickness wound healing. Stem Cells 2010 28(7):1165-77
-
(2010)
Stem Cells
, vol.28
, Issue.7
, pp. 1165-1177
-
-
Hendrickx, B.1
Verdonck, K.2
Van Den Berge, S.3
-
103
-
-
84885600726
-
Human cord blood derived unrestricted somatic stem cells promote wound healing and have therapeutic potential for patients with recessive dystrophic epidermolysis bullosa
-
Feb. [Epub ahead of print
-
Liao Y, Itoh M, Yang A, et al. Human cord blood derived unrestricted Somatic stem cells promote wound healing and have therapeutic potential for patients with recessive dystrophic epidermolysis bullosa. Cell Transplant 2013 Feb. [Epub ahead of print]
-
(2013)
Cell Transplant
-
-
Liao, Y.1
Itoh, M.2
Yang, A.3
-
104
-
-
84873046124
-
Bioprinted amniotic fluid-derived stem cells accelerate healing of large skin wounds
-
Skardal A, Mack D, Kapetanovic E, et al. Bioprinted amniotic fluid-derived stem cells accelerate healing of large skin wounds. Stem Cells Transl Med 2012á1(11):792-802
-
(2012)
Stem Cells Transl Med
, vol.1
, Issue.11
, pp. 792-802
-
-
Skardal, A.1
Mack, D.2
Kapetanovic, E.3
-
105
-
-
84877910204
-
Epidermal stem cells: An update on their potential in regenerative medicine
-
Sun X, Fu X, Han W, et al. Epidermal stem cells: An update on their potential in regenerative medicine. Expert Opin Biol Ther 2013á13(6):901- 10
-
(2013)
Expert Opin Biol Ther
, vol.13
, Issue.6
, pp. 901-910
-
-
Sun, X.1
Fu, X.2
Han, W.3
-
106
-
-
84873319153
-
Reepithelialization from stem cells of hair follicles of dermal graft of the scalp in acute treatment of third-degree burns: First clinical and histologic study
-
Coruh A, Yontar Y. Reepithelialization from stem cells of hair follicles of dermal graft of the scalp in acute treatment of third-degree burns: First clinical and histologic study. Plast Reconstr Surg 2013á131(2):275e
-
(2013)
Plast Reconstr Surg
, vol.131
, Issue.2
-
-
Coruh, A.1
Yontar, Y.2
-
107
-
-
84875056343
-
The effect of subcutaneous mesenchymal stem cell injection on statis zone and apoptosis in an experimental burn model
-
Oksuz S, Ulkur E, Oncul O, et al. The effect of subcutaneous mesenchymal stem cell injection on statis zone and apoptosis in an experimental burn model. Plast Reconstr Surg 2013á131(3):463-71
-
(2013)
Plast Reconstr Surg
, vol.131
, Issue.3
, pp. 463-471
-
-
Oksuz, S.1
Ulkur, E.2
Oncul, O.3
-
108
-
-
84883692915
-
Topical administration of allogeneic mesenchymal stem cells seeded in a collagen scaffold augments wound healing and increases angiogenesis in the diabetic rabbit ulcer
-
O'Loughlin A, Kulkarni M, Creane M, et al. Topical administration of allogeneic mesenchymal stem cells seeded in a collagen scaffold augments wound healing and increases angiogenesis in the diabetic rabbit ulcer. Diabetes 2013á62(7):2588-94
-
(2013)
Diabetes
, vol.62
, Issue.7
, pp. 2588-2594
-
-
O'Loughlin, A.1
Kulkarni, M.2
Creane, M.3
-
109
-
-
84858750133
-
The role of stem cells in the treatment of diabetic foot ulcers
-
Blumberg SN, Berger A, Hwang L, et al. The role of stem cells in the treatment of diabetic foot ulcers. Diabetes Res Clin Pract 2012á96(1):1-9
-
(2012)
Diabetes Res Clin Pract
, vol.96
, Issue.1
, pp. 1-9
-
-
Blumberg, S.N.1
Berger, A.2
Hwang, L.3
-
110
-
-
84870827252
-
Mesenchymal stem cells/multipotent mesenchymal stromal cells (mscs): Potential role in healing cutaneous chronic wounds
-
Zou JP, Huang S, Peng Y, et al. Mesenchymal stem cells/multipotent mesenchymal stromal cells (MSCs): Potential role in healing cutaneous chronic wounds. Int J Low Extrem Wounds 2012á11(4):244-53
-
(2012)
Int J Low Extrem Wounds
, vol.11
, Issue.4
, pp. 244-253
-
-
Zou, J.P.1
Huang, S.2
Peng, Y.3
-
111
-
-
84880573343
-
Autologous transplantation of adipose-derived stem cells enhances skin graft survival and wound healing in diabetic rats
-
Zografou A, Papadopoulos O, Tsigris C, et al. Autologous transplantation of adipose-derived stem cells enhances skin graft survival and wound healing in diabetic rats. Ann Plas Surg 2013á71(2):225-32
-
(2013)
Ann Plas Surg
, vol.71
, Issue.2
, pp. 225-232
-
-
Zografou, A.1
Papadopoulos, O.2
Tsigris, C.3
-
112
-
-
59649095749
-
An evidence-based model comparing the cost-effectiveness of platelet-rich plasma gel to alternative therapies for patients with nonhealing diabetic foot ulcers
-
Dougherty EJ. An evidence-based model comparing the cost-effectiveness of platelet-rich plasma gel to alternative therapies for patients with nonhealing diabetic foot ulcers. Adv Skin Wound Care 2008á21(12):568-75
-
(2008)
Adv Skin Wound Care
, vol.21
, Issue.12
, pp. 568-575
-
-
Dougherty, E.J.1
-
113
-
-
84857503111
-
Fibroblasts within concentrated collagen hydrogels favour chronic skin wound healing
-
Helary C, Zarka M, Giraud-Guille MM. Fibroblasts within concentrated collagen hydrogels favour chronic skin wound healing. J Tissue Eng Regen Med 2012á6(3):225-37
-
(2012)
J Tissue Eng Regen Med
, vol.6
, Issue.3
, pp. 225-237
-
-
Helary, C.1
Zarka, M.2
Giraud-Guille, M.M.3
-
114
-
-
58049173181
-
The use of bioactive wound dressing stimulating epithelial regeneration of iiia-degree burn wounds
-
Ermolov AS, Smirnov SV, Khvatov VB, et al. The use of bioactive wound dressing, stimulating epithelial regeneration of IIIa-degree burn wounds. Bull Exp Biol Med 2008á146(1):153-7
-
(2008)
Bull Exp Biol Med
, vol.146
, Issue.1
, pp. 153-157
-
-
Ermolov, A.S.1
Smirnov, S.V.2
Khvatov, V.B.3
-
115
-
-
80355142696
-
Pullulan hydrogels improve mesenchymal stem cell delivery into high-oxidative-stress wounds
-
Wong VW, Rustad KC, Glotzbach JP, et al. Pullulan hydrogels improve mesenchymal stem cell delivery into high-oxidative-stress wounds. Macromol Biosci 2011á11(11):1458-66
-
(2011)
Macromol Biosci
, vol.11
, Issue.11
, pp. 1458-1466
-
-
Wong, V.W.1
Rustad, K.C.2
Glotzbach, J.P.3
-
116
-
-
84873406707
-
Adipose-derived stromal cells overexpressing vascular endothelial growth factor accelerate mouse excisional wound healing
-
Nauta A, Seidel C, Deveza L, et al. Adipose-derived stromal cells overexpressing vascular endothelial growth factor accelerate mouse excisional wound healing. Mol Ther 2013á21(2):445-55
-
(2013)
Mol Ther
, vol.21
, Issue.2
, pp. 445-455
-
-
Nauta, A.1
Seidel, C.2
Deveza, L.3
-
117
-
-
2442513339
-
Protocol for treatment of diabetic foot ulcers
-
Brem H, Sheehan P, Boulton AJ. Protocol for treatment of diabetic foot ulcers. Am J Surg 2004á187(5A):1S-10S
-
(2004)
Am J Surg
, vol.187
, Issue.5
-
-
Brem, H.1
Sheehan, P.2
Boulton, A.J.3
-
118
-
-
3042660408
-
Protocol for the successful treatment of pressure ulcers
-
Suppl
-
Brem H, Lyder C. Protocol for the successful treatment of pressure ulcers. Am J Surg 2004á188(1A Suppl):9-17
-
(2004)
Am J Surg
, vol.188
, Issue.1
, pp. 9-17
-
-
Brem, H.1
Lyder, C.2
-
119
-
-
0039334754
-
Biobrane improves wound healing in burned children without increased risk of infection
-
discussion 318-319
-
Lal S, Barrow RE,Wolf SE, et al. Biobrane improves wound healing in burned children without increased risk of infection. Shock 2000á14(3): 314-18á discussion 318-19
-
(2000)
Shock
, vol.14
, Issue.3
, pp. 314-318
-
-
Lal, S.1
Barrow, R.E.2
Wolf, S.E.3
-
120
-
-
84863604436
-
Total contact casting combined with human fibroblast-derived dermal tissue in 15 dfu patients
-
238, 240 242-233
-
Kashefsky H, Marston W. Total contact casting combined with human fibroblast-derived dermal tissue in 15 DFU patients. J Wound Care 2012á21(5):236á 238, 240, 242-233
-
(2012)
J Wound Care
, vol.21
, Issue.5
, pp. 236
-
-
Kashefsky, H.1
Marston, W.2
-
121
-
-
82255179890
-
Human fibroblast-derived dermal substitute: Results from a treatment investigational device exemption (tide) study in diabetic foot ulcers
-
Warriner RA III, Cardinal M. Human fibroblast-derived dermal substitute: Results from a treatment investigational device exemption (TIDE) study in diabetic foot ulcers. Adv Skin Wound Care 2011á24(7):306-11
-
(2011)
Adv Skin Wound Care
, vol.24
, Issue.7
, pp. 306-311
-
-
Warriner III, R.A.1
Cardinal, M.2
-
122
-
-
0033945354
-
Recombinant human platelet-derived growth factor-bb (becaplermin) for healing chronic lower extremity diabetic ulcers: An open-label clinical evaluation of efficacy
-
Embil JM, Papp K, Sibbald G, et al. Recombinant human platelet-derived growth factor-BB (becaplermin) for healing chronic lower extremity diabetic ulcers: An open-label clinical evaluation of efficacy. Wound Repair Regen 2000á8(3):162-8
-
(2000)
Wound Repair Regen
, vol.8
, Issue.3
, pp. 162-168
-
-
Embil, J.M.1
Papp, K.2
Sibbald, G.3
-
123
-
-
0028069703
-
A phase ii study to evaluate recombinant platelet-derived growth factor-bb in the treatment of stage 3 and 4 pressure ulcers
-
Mustoe TA, Cutler NR, Allman RM, et al. A Phase II study to evaluate recombinant platelet-derived growth factor-BB in the treatment of stage 3 and 4 pressure ulcers. Arch Surg 1994á129(2):213-19
-
(1994)
Arch Surg
, vol.129
, Issue.2
, pp. 213-219
-
-
Mustoe, T.A.1
Cutler, N.R.2
Allman, R.M.3
-
124
-
-
84862833125
-
The clinical relevance of treating chronic wounds with an enhanced near-physiological concentration of platelet-rich plasma gel
-
de Leon JM, Driver VR, Fylling CP, et al. The clinical relevance of treating chronic wounds with an enhanced near-physiological concentration of platelet-rich plasma gel. Adv Skin Wound Care 2011á24(8):357-68
-
(2011)
Adv Skin Wound Care
, vol.24
, Issue.8
, pp. 357-368
-
-
De Leon, J.M.1
Driver, V.R.2
Fylling, C.P.3
|